Eduardo Carlos
Salido Ruiz
Catedrático de Universidad
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (5)
2022
-
Molecular diagnosis in non-small-cell lung cancer: Expert opinion on ALK and ROS1 testing
Journal of Clinical Pathology, Vol. 75, Núm. 3, pp. 145-153
2021
-
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer
Oncogene, Vol. 40, Núm. 16, pp. 2923-2935
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2018
-
Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus
Kidney International Reports, Vol. 3, Núm. 6, pp. 1304-1315
2015
-
Estimated glomerular filtration rate in renal transplantation: The nephrologist in the mist
Transplantation, Vol. 99, Núm. 12, pp. 2625-2633